Molecular and Sociodemographic Colorectal Cancer Disparities in Latinos Living in Puerto Rico
- PMID: 37107652
- PMCID: PMC10138302
- DOI: 10.3390/genes14040894
Molecular and Sociodemographic Colorectal Cancer Disparities in Latinos Living in Puerto Rico
Abstract
Background: The incidence of sporadic colorectal cancer (CRC) among individuals <50 years (early-onset CRC) has been increasing in the United States (U.S.) and Puerto Rico. CRC is currently the leading cause of cancer death among Hispanic men and women living in Puerto Rico (PRH). The objective of this study was to characterize the molecular markers and clinicopathologic features of colorectal tumors from PRH to better understand the molecular pathways leading to CRC in this Hispanic subpopulation.
Methods: Microsatellite instability (MSI), CpG island methylator phenotype (CIMP), and KRAS and BRAF mutation status were analyzed. Sociodemographic and clinicopathological characteristics were evaluated using Chi-squared and Fisher's exact tests.
Results: Of the 718 tumors analyzed, 34.2% (n = 245) were early-onset CRC, and 51.7% were males. Among the tumors with molecular data available (n = 192), 3.2% had MSI, 9.7% had BRAF, and 31.9% had KRAS mutations. The most common KRAS mutations observed were G12D (26.6%) and G13D (20.0%); G12C was present in 4.4% of tumors. A higher percentage of Amerindian admixture was significantly associated with early-onset CRC.
Conclusions: The differences observed in the prevalence of the molecular markers among PRH tumors compared to other racial/ethnic groups suggest a distinct molecular carcinogenic pathway among Hispanics. Additional studies are warranted.
Keywords: Hispanics; colorectal cancer; early-onset colorectal cancer; molecular markers.
Conflict of interest statement
MCC reports research support from the following pharmaceutical companies: Abbvie, BMS, Regeneron, QED, SeaGen, Janssen, TAIHO, BeiGene, MIRATI, Merck, Gilead, Pfizer, Natera, Genentech, Elli Lilly, and Apollomics. The content of this manuscript is not related to the research support from the pharmaceutical industry.
References
-
- Gonzalez-Pons M., Torres M., Perez J., Velez A., Betancourt J.P., Marcano L., Soto-Salgado M., Cruz-Correa M. Colorectal Cancer Survival Disparities among Puerto Rican Hispanics: A Comparison to Racial/Ethnic Groups in the United States. Cancer Clin. Oncol. 2016;5:29–37. doi: 10.5539/cco.v5n2p29. - DOI - PMC - PubMed
-
- Zavala V.A., Bracci P.M., Carethers J.M., Carvajal-Carmona L., Coggins N.B., Cruz-Correa M.R., Davis M., de Smith A.J., Dutil J., Figueiredo J.C., et al. Cancer health disparities in racial/ethnic minorities in the United States. Br. J. Cancer. 2020;124:315–332. doi: 10.1038/s41416-020-01038-6. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous
